257 related articles for article (PubMed ID: 7436516)
1. Gentamicin and tobramycin compared in the treatment of mucoid pseudomonas lung infections in cystic fibrosis.
Martin AJ; Smalley CA; George RH; Healing DE; Anderson CM
Arch Dis Child; 1980 Aug; 55(8):604-7. PubMed ID: 7436516
[TBL] [Abstract][Full Text] [Related]
2. Tobramycin and carbenicillin compared with gentamicin and carbenicillin in the treatment of infection with Pseudomonas aeruginosa in adult patients with cystic fibrosis.
Hodson ME; Wingfield HJ; Batten JC
Br J Dis Chest; 1983 Jan; 77(1):71-7. PubMed ID: 6407508
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy of chronic infections with mucoid Pseudomonas aeruginosa in lower airways of patients with cystic fibrosis.
Friis B
Scand J Infect Dis; 1979; 11(3):211-7. PubMed ID: 118525
[TBL] [Abstract][Full Text] [Related]
4. Tobramycin in treatment of infections due to Pseudomonas aeruginosa in patients with cystic fibrosis.
Crozier DN; Khan SR
J Infect Dis; 1976 Aug; 134 Suppl():S187-90. PubMed ID: 823275
[TBL] [Abstract][Full Text] [Related]
5. Ceftazidime compared with gentamicin and carbenicillin in patients with cystic fibrosis, pulmonary pseudomonas infection, and an exacerbation of respiratory symptoms. British Thoracic Society Research Committee.
Thorax; 1985 May; 40(5):358-63. PubMed ID: 2862713
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of ticarcillin plus tobramycin versus carbenicillin plus gentamicin for the treatment of serious infections due to gram-negative bacilli.
Parry MF; Neu HC
Am J Med; 1978 Jun; 64(6):961-6. PubMed ID: 247895
[TBL] [Abstract][Full Text] [Related]
7. Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosis.
Parry MF; Neu HC
J Infect Dis; 1976 Aug; 134 Suppl():S194-7. PubMed ID: 823276
[TBL] [Abstract][Full Text] [Related]
8. Ticarcillin compared with carbenicillin in the treatment of exacerbations of bronchopulmonary infection in cystic fibrosis.
Penketh AR; Hodson ME; Batten JC
Br J Dis Chest; 1983 Apr; 77(2):179-84. PubMed ID: 6871085
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
Møller NE; Høiby N
Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884
[TBL] [Abstract][Full Text] [Related]
10. [Pseudomonas infections in lungs of children born with cystic fibrosis. Effects and adverse effects during antibiotic therapy with tobramycin and carbenicillin].
Friis B; Thomsen J
Ugeskr Laeger; 1979 Jul; 141(29):1968-72. PubMed ID: 545764
[No Abstract] [Full Text] [Related]
11. Piperacillin and tobramycin in the treatment of Pseudomonas lung infections in cystic fibrosis.
Hoogkamp-Korstanje JA; van der Laag J
J Antimicrob Chemother; 1983 Aug; 12(2):175-83. PubMed ID: 6619055
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of high-dose tobramycin-carbenicillin therapy in pseudomonal infections in cystic fibrosis.
Fraser GL; Valenti AJ; Grimes GR; Corbin RP
Drug Intell Clin Pharm; 1985 Oct; 19(10):757-61. PubMed ID: 4053983
[TBL] [Abstract][Full Text] [Related]
13. Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis.
Permin H; Koch C; Høiby N; Christensen HO; Møller AF; Møller S
J Antimicrob Chemother; 1983 Jul; 12 Suppl A():313-23. PubMed ID: 6352636
[TBL] [Abstract][Full Text] [Related]
14. Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
Cheer SM; Waugh J; Noble S
Drugs; 2003; 63(22):2501-20. PubMed ID: 14609360
[TBL] [Abstract][Full Text] [Related]
15. Intensive treatment of pseudomonas chest infection in cystic fibrosis: a comparison of tobramycin and ticarcillin, and netilmicin and ticarcillin.
Conway SP; Miller MG; Ramsden C; Littlewood JM
Acta Paediatr Scand; 1985 Jan; 74(1):107-13. PubMed ID: 3885674
[TBL] [Abstract][Full Text] [Related]
16. Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.
Penketh A; Hodson ME; Gaya H; Batten JC
Thorax; 1984 Apr; 39(4):299-304. PubMed ID: 6426075
[TBL] [Abstract][Full Text] [Related]
17. High dosage tobramycin treatment of children with cystic fibrosis. Bacteriological effect and clinical ototoxicity.
Thomsen J; Friis B
Int J Pediatr Otorhinolaryngol; 1979 Jul; 1(1):33-40. PubMed ID: 553884
[TBL] [Abstract][Full Text] [Related]
18. Comparison of tobramycin, gentamicin, colistin, and carbenicillin in Pseudomonas sepsis in monkeys.
Saslaw S; Carlisle HN; Moheimani M
Antimicrob Agents Chemother; 1972 Sep; 2(3):164-72. PubMed ID: 4208275
[TBL] [Abstract][Full Text] [Related]
19. Tobramycin therapy of infections due to Pseudomonas aeruginosa in patients with cystic fibrosis: effect of dosage and concentration of antibiotic in sputum.
McCrae WM; Raeburn JA; Hanson EJ
J Infect Dis; 1976 Aug; 134 Suppl():S191-3. PubMed ID: 972281
[TBL] [Abstract][Full Text] [Related]
20. Inhaled tobramycin (TOBI).
Bonsignore CL
Pediatr Nurs; 1998; 24(3):258-9. PubMed ID: 9987427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
